0001188112-13-001856.txt : 20130620 0001188112-13-001856.hdr.sgml : 20130620 20130620160558 ACCESSION NUMBER: 0001188112-13-001856 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130614 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20130620 DATE AS OF CHANGE: 20130620 FILER: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED DNA SCIENCES INC CENTRAL INDEX KEY: 0000744452 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 592262718 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 002-90539 FILM NUMBER: 13924552 BUSINESS ADDRESS: STREET 1: 25 HEALTH SCIENCES DRIVE STREET 2: SUITE 113 CITY: STONY BROOK STATE: NY ZIP: 11790 BUSINESS PHONE: 631 444 6861 MAIL ADDRESS: STREET 1: 25 HEALTH SCIENCES DRIVE STREET 2: SUITE 113 CITY: STONY BROOK STATE: NY ZIP: 11790 FORMER COMPANY: FORMER CONFORMED NAME: PROHEALTH MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 20010504 FORMER COMPANY: FORMER CONFORMED NAME: DCC ACQUISITION CORP DATE OF NAME CHANGE: 19990211 FORMER COMPANY: FORMER CONFORMED NAME: DATALINK CAPITAL CORP/TX/ DATE OF NAME CHANGE: 19980306 8-K 1 t76815_8k.htm Unassociated Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 

Date of report (Date of earliest event reported):  June 14, 2013
 
Applied DNA Sciences, Inc.
 
(Exact Name of Registrant as Specified in Charter)
 
Delaware
(State or Other Jurisdiction
of Incorporation)
002-90539
(Commission File Number)
59-2262718
(IRS Employer
Identification No.)
 
50 Health Sciences Drive
Stony Brook, New York 11790
(Address of Principal Executive Offices) (Zip Code)
 
631-444- 8090
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 40.14d - (b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e - (c))
 
 
 
 
Item 1.01.  
Entry into a Material Definitive Agreement.
 
On June 14, 2013, Applied DNA Sciences, Inc., as tenant (the “Company”), entered into a lease with Long Island High Technology Incubator, Inc., as landlord (“LIHTI”), with respect to 50 Health Sciences Drive, Stony Brook, NY, a 30,000 rentable square foot building located on the campus of the State University of New York at Stony Brook (“Premises”).  The term of the lease commenced on June 15, 2013 and expires May 31, 2016.  The Company has the option to extend the lease term for two additional three-year periods.  The base rent during the initial lease term is $449,142 per annum.  At the commencement of each renewal term (if any), the base rent would be subject to a Consumer Price Index (“CPI”) increase reflecting the CPI increase, if any, that occurred since the commencement of the lease term.  The Company is required to pay for ordinary Premises operating expenses, but not real estate taxes with respect thereto.  Further, pursuant to the lease, LIHTI, at its sole cost and expense, is responsible for maintaining and replacing the structural elements of the Premises, including the installation of a new roof within the next 12 months, and has expressly agreed to replace the HVAC systems and all equipment and fixtures located outside the Premises, but serving the Premises, at the end of their useful lives.  As required under the lease, the Company will deliver a $50,000 lease security deposit to LIHTI.  The Premises replace a lesser amount of space, leased by the Company from LIHTI in an adjacent building located at 25 Health Sciences Drive, Stony Brook, NY.
 
 
 
 

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Applied DNA Sciences, Inc.
(Registrant)
  
       
       
       
 
By:
/s/ James A. Hayward  
   
James A. Hayward
  
   
Chief Executive Officer
  
       
       
Date:           June 20, 2013